Condition

Early-stage HER2+ Breast Cancer clinical trials and research

• 2Clinical trials
• 3Countries

All recruiting trials (2)

• Treatment patterns and adherence after decentralizing care for early HER2-positive breast cancer

  This study tests whether moving adjuvant HER2-targeted treatment closer to patients helps people with early-stage HER2-positive breast cancer stick to their therapy.

  Recruiting at 10 sites Hoffmann-La Roche · Loznica, Bolnička 65 and 9 other locations · NCT07527741

• 6 months versus 12 months of HER2-targeted therapy after a complete response to preoperative chemo for early HER2+ breast cancer

  This tests whether 6 months of HER2-targeted therapy works as well as 12 months for people with early HER2+ breast cancer who had a pathologic complete response after preoperative chemotherapy with trastuzumab.

  Recruiting at 604 sites Phase 3 Alliance for Clinical Trials in Oncology · Phoenix, Arizona and 701 other locations · NCT06876714

Related topics

Quick answers

How many Early-stage HER2+ Breast Cancer clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Serbia (1 trial), Puerto Rico (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →